# Short-Term Endogenous Hydrogen Sulfide Upregulation For Vein Graft Disease

> **NCT05457881** · NA · WITHDRAWN · sponsor: **Brigham and Women's Hospital**

## Conditions studied

- Vascular Diseases
- Surgery

## Interventions

- **DIETARY_SUPPLEMENT:** Scandi-Shake

## Key facts

- **NCT ID:** NCT05457881
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-03-01
- **Primary completion:** 2029-03-01
- **Final completion:** 2029-12-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Insufficient funds to start study
- **Last updated:** 2025-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05457881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05457881, "Short-Term Endogenous Hydrogen Sulfide Upregulation For Vein Graft Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05457881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*